✦ LIBER ✦

Fracture Risk and Bone Mineral Density Reduction Associated with Proton Pump Inhibitors

✍ Scribed by Yuen Ting Lau; Nasiya N. Ahmed

Book ID: 112174481
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 121 KB
Volume: 32
Category: Article
ISSN: 0277-0008
DOI: 10.1002/phar.1007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proton-Pump Inhibitor Use Is Not Associa

Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss

✍ Laura E. Targownik; Lisa M. Lix; Stella Leung; William D. Leslie 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Long-term therapy with proton pump inhib

Long-term therapy with proton pump inhibitors is associated with decreased bone density

✍ Andre Bratanic; Slaven Kokic; Izet Hozo; Igor Barisic; Visnja Kokic 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Proton pump inhibitor omeprazole use is

Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients

✍ A. Kirkpantur; B. Altun; M. Arici; C. Turgan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

415 The Use of Proton Pump Inhibitors Is

415 The Use of Proton Pump Inhibitors Is Not Associated with Accelerated Bone Mineral Loss

✍ Laura E. Targownik; Lisa M. Lix; Stella Leung; William D. Leslie 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Associations ofAPOEgene polymorphisms wi

Associations ofAPOEgene polymorphisms with bone mineral density and fracture risk: a meta-analysis

✍ I. Peter; M. D. Crosier; M. Yoshida; S. L. Booth; L. A. Cupples; B. Dawson-Hughe 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 466 KB

Relationship between bone mineral densit

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures

✍ Matthew Austin; Yu-Ching Yang; Eric Vittinghoff; Silvano Adami; Steven Boonen; D 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 96 KB

Dual-energy X-ray absorptiometric bone mineral density (DXA BMD) is a strong predictor of fracture risk in untreated patients. However, previous patient-level studies suggest that BMD changes explain little of the fracture risk reduction observed with osteoporosis treatment. We investigated the rele